期刊文献+

成人与儿童下呼吸道感染患者的病原菌分布及耐药性分析 被引量:9

Analysis of distribution and drug resistance of pathogens causing lower respiratory tract infections in adult and pediatric patients
原文传递
导出
摘要 目的研究成人与儿童下呼吸道感染患者的病原菌分布及耐药性,为临床合理使用抗菌药物提供参考。方法选取2012年1月-2014年6月住院的成人与儿童下呼吸道感染患者为研究对象,成人组患者年龄21~65岁,儿童组患者年龄4~14岁,对比两组患者的病原菌分布及耐药性。结果成人与儿童患者感染病原菌均以革兰阴性菌为主,分别占74.1%、69.5%,革兰阳性菌分别为17.5%、23.2%;成人患者感染的主要革兰阴性菌对哌拉西林/他唑巴坦的耐药率最低为〈15.0%,对阿米卡星、庆大霉素耐药率均〈35.0%,儿童感染的主要革兰阴性菌对头孢哌酮/舒巴坦的耐药率均为0,对阿米卡星、哌拉西林/他唑巴坦的耐药率均〈10.0%,对庆大霉素的耐药率均〈30.0%;成人感染的主要革兰阳性菌对哌拉西林/他唑巴坦的耐药率〈35.0%,儿童感染的主要革兰阳性菌对左氧氟沙星、哌拉西林/他唑巴坦的耐药率均〈15.0%,对庆大霉素的耐药率均〈30.0%。结论成人与儿童下呼吸道感染的病原菌分布及其耐药性具有一定的差异性,医师应加强细菌培养和耐药性检测,有助于患者临床合理使用抗菌药物。 OBJECTIVE To study the distribution and drug resistance of pathogens causing lower respiratory tract infections in adult and pediatric patients in our hospital ,so as to provide references for rational use of antibiotics . METHODS Adults or children with low respiratory tract infections admitted from Jan .2012 to Jun .2014 were se‐lected as study objects .Adult group aged 21 to 65 and children group aged 4 to 14 .The pathogen distribution and drug resistance of the two groups were compared .RESULTS Gram‐negative bacteria were found to be the main cause of infections .Totally 74 .1% of adults were found to be infected by gram‐negative bacteria ,and 69 .5% of children .And 17 .5% of adults were found to be infected by gram‐positive bacteria ,and 23 .2% of children .In a‐dult group ,the drug resistance rate of gram‐negative bacteria to piperacillin/tazobactam was the lowest (less than 15 .0% ) ,and to amikacin and gentamicin ,it was less than 35 .0% .In the children group ,gram‐negative bacteria were found to be totally sensitive to cefoperazone and sulbactam ,and slightly resistant to amikacin ,piperacillin and tazobactam (less than 10 .0% ) and moderately resistant to gentamicin (less than 30 .0% ) .In adult group ,the drug resistance rate of gram‐positive bacteria to piperacillin/tazobactam was less than 35 .0% .And the drug rsis‐tance rates of gram‐positive bacteria to levofloxacin and piperacillin/tazobactam were less than 15 .0% ,followed by gentamicin with the rate less than 30 .0% .CONCLUSION Differences were found in the pathogen distribution and drug resistance between adults and children .Bacteria culture and drug resistance detection need to be strengthened to help clinical rational use of antibiotics for patients .
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2015年第20期4610-4612,共3页 Chinese Journal of Nosocomiology
基金 国家自然科学基金资助项目(30470877)
关键词 下呼吸道感染 病原菌 耐药性 Lower respiratory tract infection Pathogen Drug resistance
  • 相关文献

参考文献8

二级参考文献68

  • 1黄文焰,郑军.肺部感染病原菌的变迁及检测[J].中国热带医学,2005,5(5):1084-1085. 被引量:3
  • 2张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:138
  • 3王文晶,黄茂,赵旺胜,殷凯生.下呼吸道感染病原体流行和耐药现状分析[J].南京医科大学学报(自然科学版),2006,26(1):29-32. 被引量:24
  • 4金敏雅,林平.老年住院病人下呼吸道感染病原菌分布与耐药性分析[J].现代预防医学,2007,34(10):1984-1985. 被引量:5
  • 5王晶,韩丽霞,张凤华,杨秋红.儿童呼吸道感染病原菌分布与耐药分析[J].中国感染控制杂志,2007,6(3):180-182. 被引量:15
  • 6李远志,白晓梅,贺智英.细菌的耐药机制[J].延安大学学报(医学科学版),2007,5(1):6-7. 被引量:4
  • 7Philippon A, Labia R, Jaeoby G. Extended-spectrum beta- lactamases [ J ]. Antimicrob Agents Chemother, 1989,33 (8):1 131-1 136.
  • 8Hetem DJ, De Ruiter SC, Buiting AG, et al. preventing staphylo-coccus aureus bacteremia and sepsis in patients with staphylococcusaureus colonization of intravascular catheters : a retrospective multi-center study and meta analysis [ J]. Medicine ( Baltimore ) ,2011,90(4):284 -8.
  • 9Hill PC,Birch M,Chambers S,et al. Prospective study of 424 casesof staphylococcus aureus bacteraemia : determination of factors affect-ing incidence and mortality [ J] . Inter Med J, 2001 ,31 (2 ) :97 -103.
  • 10Hare K M, Singleton R J, Grimwood K,et al. Longitudinal na- sopharyngeal carriage and antibiotic resistance of respiratory bacleria in indigenous Australian and Alaska native children with bronchiectasis[J]. PloS one, 2013,8(8) :e70478.

共引文献66

同被引文献93

  • 1Alburquenque C, Beltran S, Olivares R, et al. Species dis-tribution and susceptibility pattern of Candida spp. : the im-portance to survey also strains isolated from the community[J]. Rev Chilena Infectol, 2013,30 (3) : 244-251.
  • 2Queenan AM, Davies TA,He W, et al. Assessment of thecombination of doripenem plus a fluoroquinolone againstnon-susceptible Acinetobacter baumannii isolates from noso-comial pneumonia patients [J]. J Chemother, 2013,25(3): 141-147.
  • 3Clinical and Laboratory Standards Institute. Performance stand-ards for antimicrobial susceptibility testing, Twentieth informa-tional supplement [S]. CLSI,2010,M100-S20; 16-32.
  • 4Pourhajibagher M, Hashemi FB, Pourakbari B, et al. Anti-microbial Resistance of Acinetobacter baumannii to Imipen-em in Iran: A Systematic Review and Meta-Analysis [J].Open Microbiol J, 2016,10: 32-42.
  • 5Richmond GE, Evans LP, Anderson MJ , et at. The acineto-bacter baumannii two-component system aders regulatesgenes required for multidrug efflux, biofilm formation, and vir-ulence in a strain-specific manner [J]. MBio, 2016,7 (3):e00852.
  • 6Jones RN. Microbial etiologies of hospital-acquired bacterialpneumonia and ventilator-associated bacterial pneumonia[J]. Clin Infect Dis? 2010, 51 Suppl 1: S81-87.
  • 7Liu YM, Chen YS, Toh HS,et al. In vitro susceptibilitiesof non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to2010. results from the study for monitoring antimicrobialresistance trends (SMART) [J]. Int J Antimicrob Agents,2012,40 Suppl; Sll-17.
  • 8Xiao M,Wang Y, Yang QW,et al. Antimicrobial suscepti-bility of pseudomonas aeruginosa in China : a review of twomulticentre surveillance programmes, and application of re-vised CLSI susceptibility breakpoints [J]. Int J AntimicrobAgents, 2012,40 ?5) : 445-449.
  • 9Cetinkol Y, Yildirim AA, Telli M, et al. The investigationof oxacillinase/metallo-beta-lactamase genes and clonal anal-ysis in carbapenem-resistant Klebsiella pneumoniae [J]. In-fez Med, 2016,24 (1) : 48-53.
  • 10PEREZ F,HUJER A M, HUJER K M, et al Global challenge ofmultiple drug - resistance of Acinetobacter baumannii. AntimicrobAgents Chemother, 2007, 51(10) :3471 -3484.

引证文献9

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部